stock · yahoo
Regeneron Pharmaceuticals, Inc.
REGN
$628.73
▲ 9.78 (1.58%)
polled · warming up
Unten findest du den Live-Kurs für Regeneron Pharmaceuticals, Inc. (REGN), einen 1-Jahres-Chart, 8 Indikatoren (RSI, MACD, Bollinger, MA, EMA, Stochastic, ATR, Volumen) und einen Vergleichsmodus. Hinzufügen zum Portfolio, auf die Beobachtungsliste setzen oder einen Preisalarm einrichten — alles in einem.
Day
+1.58%
+9.78
Week
+1.16%
+7.21
Month
-10.47%
-73.54
Year
—
- Prev close
- $618.95
- Volume
- $974.34K
- Market cap
- $65.92B
- Currency
- USD
Aktuelle Nachrichten
- REGN Expands Cancer Deal With CytomX for Bispecific TherapeuticsZacks9h ago
- Regeneron to Highlight Progress Across Its Metabolic Disease, Ophthalmology and Rare Disease Pipelines at ADA and ENDOGlobeNewswire16h ago
- Why Regeneron (REGN) Stock Is Trading Up TodayStockStory1d ago
- Analyst Report: Intellia Therapeutics, Inc.Morningstar Research4h ago
- Sanofi Stock Falls 6% in 3 Months: Should You Buy, Sell or Hold?Zacks14h ago
- How Investors May Respond To Regeneron (REGN) EMA Fast-Track Review Of Otarmeni Gene TherapySimply Wall St.1d ago
- Regeneron and CytomX extend cancer therapy partnership to $4bn dealPharmaceutical Technology17h ago
- 2 S&P 500 Stocks with Solid Fundamentals and 1 We Find RiskyStockStory1d ago
Live-Diskussion
Anmelden to join the discussion.
- Noch keine Kommentare. Sei der Erste.